| Amgen (AMGN) |
United States |
$108.806B |
12.30 |
| Gilead Sciences (GILD) |
United States |
$82.919B |
10.07 |
| Celgene (CELG) |
United States |
$63.614B |
10.78 |
| Biogen (BIIB) |
United States |
$44.842B |
8.51 |
| Vertex Pharmaceuticals (VRTX) |
United States |
$44.598B |
53.91 |
| Illumina (ILMN) |
United States |
$43.100B |
49.95 |
| CSL (CSLLY) |
Australia |
$35.794B |
0.00 |
| Regeneron Pharmaceuticals (REGN) |
United States |
$32.576B |
15.31 |
| Actelion (ALIOF) |
Switzerland |
$29.891B |
0.00 |
| Alexion Pharmaceuticals (ALXN) |
United States |
$27.088B |
15.33 |
| Incyte (INCY) |
United States |
$17.271B |
70.04 |
| Exact Sciences (EXAS) |
United States |
$14.835B |
0.00 |
| BioMarin Pharmaceutical (BMRN) |
United States |
$14.607B |
0.00 |
| SINO PHARMACEUT (SBMFF) |
China |
$14.154B |
0.00 |
| Seattle Genetics (SGEN) |
United States |
$12.140B |
0.00 |
| Sarepta Therapeutics (SRPT) |
United States |
$11.068B |
0.00 |
| Genmab (GNMSF) |
Denmark |
$11.046B |
56.15 |
| Array BioPharma (ARRY) |
United States |
$10.373B |
0.00 |
| Galapagos (GLPG) |
Belgium |
$9.396B |
0.00 |
| Bio-Rad Laboratories (BIO.B) |
United States |
$9.283B |
49.21 |
| QIAGEN (QGEN) |
Netherlands |
$8.917B |
29.29 |
| Guardant Health (GH) |
United States |
$8.158B |
0.00 |
| Alnylam Pharmaceuticals (ALNY) |
United States |
$8.030B |
0.00 |
| Bio-Techne Corp (TECH) |
United States |
$7.933B |
54.13 |
| Bluebird Bio (BLUE) |
United States |
$7.614B |
0.00 |
| Exelixis (EXEL) |
United States |
$6.419B |
16.36 |
| Amarin (AMRN) |
Ireland |
$5.979B |
0.00 |
| BeiGene (BGNE) |
Cayman Islands |
$5.801B |
0.00 |
| Ascendis Pharma (ASND) |
Denmark |
$4.841B |
0.00 |
| Blueprint Medicines (BPMC) |
United States |
$4.775B |
0.00 |
| ARGENX SE-ADR (ARGX) |
Netherlands |
$4.762B |
0.00 |
| Moderna (MRNA) |
United States |
$4.642B |
0.00 |
| Horizon Pharma Public (HZNP) |
Ireland |
$4.456B |
11.48 |
| Repligen (RGEN) |
United States |
$4.099B |
102.12 |
| Mirati Therapeutics (MRTX) |
United States |
$3.821B |
0.00 |
| Spark Therapeutics (ONCE) |
United States |
$3.720B |
0.00 |
| ACADIA Pharmaceuticals (ACAD) |
United States |
$3.705B |
0.00 |
| China Biologic Products (CBPO) |
China |
$3.661B |
23.25 |
| Alkermes (ALKS) |
Ireland |
$3.651B |
0.00 |
| Ultragenyx Pharmaceutical (RARE) |
United States |
$3.569B |
0.00 |
| MorphoSys AG (MOR) |
Germany |
$3.528B |
0.00 |
| Arena Pharmaceuticals (ARNA) |
United States |
$3.064B |
6.23 |
| Amicus Therapeutics (FOLD) |
United States |
$2.934B |
0.00 |
| Immunomedics (IMMU) |
United States |
$2.860B |
0.00 |
| UniQure (QURE) |
Netherlands |
$2.736B |
0.00 |
| Medicines (MDCO) |
United States |
$2.670B |
0.00 |
| Reata Pharmaceuticals (RETA) |
United States |
$2.620B |
0.00 |
| CRISPR Therapeutics AG (CRSP) |
Switzerland |
$2.595B |
0.00 |
| MyoKardia (MYOK) |
United States |
$2.466B |
0.00 |
| Halozyme Therapeutics (HALO) |
United States |
$2.370B |
0.00 |
| Nabriva Therapeutics AG (NBRV) |
Ireland |
$2.357B |
0.00 |
| NeoGenomics (NEO) |
United States |
$2.277B |
149.06 |
| Emergent Biosolutions (EBS) |
United States |
$2.269B |
19.71 |
| Ligand Pharmaceuticals (LGND) |
United States |
$2.233B |
18.49 |
| Acceleron Pharma (XLRN) |
United States |
$2.230B |
0.00 |
| Myriad Genetics (MYGN) |
United States |
$2.092B |
20.81 |
| Genomic Health (GHDX) |
United States |
$2.075B |
44.07 |
| Zai Lab (ZLAB) |
China |
$2.068B |
0.00 |
| Intercept Pharmaceuticals (ICPT) |
United States |
$2.044B |
0.00 |
| Akcea Therapeutics (AKCA) |
United States |
$2.041B |
0.00 |
| Denali Therapeutics (DNLI) |
United States |
$1.988B |
0.00 |
| REGENXBIO (RGNX) |
United States |
$1.800B |
0.00 |
| Insmed (INSM) |
United States |
$1.720B |
0.00 |
| Cambrex (CBM) |
United States |
$1.514B |
19.15 |
| AnaptysBio (ANAB) |
United States |
$1.474B |
0.00 |
| RA PHARMCTL INC (RARX) |
United States |
$1.418B |
0.00 |
| Fate Therapeutics (FATE) |
United States |
$1.393B |
0.00 |
| Innoviva (INVA) |
United States |
$1.361B |
3.76 |
| Sangamo Therapeutics (SGMO) |
United States |
$1.338B |
0.00 |
| Alector (ALEC) |
United States |
$1.298B |
0.00 |
| Athenex (ATNX) |
United States |
$1.278B |
0.00 |
| Coherus BioSciences (CHRS) |
United States |
$1.226B |
0.00 |
| Orchard Therapeutics (ORTX) |
United Kingdom |
$1.185B |
0.00 |
| Editas Medicine (EDIT) |
United States |
$1.174B |
0.00 |
| Epizyme (EPZM) |
United States |
$1.156B |
0.00 |
| Dicerna Pharmaceuticals (DRNA) |
United States |
$1.032B |
0.00 |
| Cara Therapeutics (CARA) |
United States |
$1.030B |
0.00 |
| Codexis (CDXS) |
United States |
$1.011B |
0.00 |
| Twist Bioscience (TWST) |
United States |
$0.982B |
0.00 |
| ANI Pharmaceuticals (ANIP) |
United States |
$0.973B |
17.25 |
| Zymeworks (ZYME) |
Canada |
$0.952B |
0.00 |
| Momenta Pharmaceuticals (MNTA) |
United States |
$0.947B |
0.00 |
| Principia Biopharma (PRNB) |
United States |
$0.921B |
0.00 |
| Adverum Biotechnologies (ADVM) |
United States |
$0.891B |
0.00 |
| ZIOPHARM Oncology Inc (ZIOP) |
United States |
$0.884B |
0.00 |
| Retrophin (RTRX) |
United States |
$0.879B |
0.00 |
| BAVARIAN NORDIC (BVNRY) |
Denmark |
$0.856B |
0.00 |
| Vericel (VCEL) |
United States |
$0.822B |
0.00 |
| Alder BioPharmaceuticals (ALDR) |
United States |
$0.820B |
0.00 |
| WAVE Life Sciences (WVE) |
Singapore |
$0.794B |
0.00 |
| Arvinas (ARVN) |
United States |
$0.789B |
0.00 |
| Intellia Therapeutics (NTLA) |
United States |
$0.782B |
0.00 |
| Precision BioSciences (DTIL) |
United States |
$0.701B |
0.00 |
| Zealand Pharma (ZEAL) |
Denmark |
$0.692B |
8.08 |
| Vanda Pharmaceuticals (VNDA) |
United States |
$0.688B |
32.47 |
| Zealand Pharma (ZLDPF) |
Denmark |
$0.683B |
0.00 |
| Intra-Cellular Therapies (ITCI) |
United States |
$0.652B |
0.00 |
| Cytokineticsorporated (CYTK) |
United States |
$0.643B |
0.00 |
| Cellectis S.A (CLLS) |
France |
$0.634B |
0.00 |
| Heska (HSKA) |
United States |
$0.622B |
63.66 |
| Autolus Therapeutics (AUTL) |
United Kingdom |
$0.612B |
0.00 |
| DBV Technologies S.A (DBVT) |
France |
$0.600B |
0.00 |
| Stemline Therapeutics (STML) |
United States |
$0.588B |
0.00 |
| Clovis Oncology (CLVS) |
United States |
$0.580B |
0.00 |
| Anika Therapeutics (ANIK) |
United States |
$0.577B |
19.72 |
| Lexicon Pharmaceuticals (LXRX) |
United States |
$0.561B |
0.00 |
| OXFORD BIOMEDCL (OXBDF) |
United Kingdom |
$0.560B |
0.00 |
| Revance Therapeutics (RVNC) |
United States |
$0.554B |
0.00 |
| CytomX Therapeutics (CTMX) |
United States |
$0.527B |
0.00 |
| Pharming Group (PHGUF) |
Netherlands |
$0.521B |
0.00 |
| MiMedx (MDXG) |
United States |
$0.503B |
0.00 |
| Mesoblast (MESO) |
Australia |
$0.494B |
0.00 |
| PHARMA MAR SA (PHMMF) |
Spain |
$0.452B |
0.00 |
| UROGEN PHARMA (URGN) |
United States |
$0.438B |
0.00 |
| Basilea Pharmaceutica AG (BPMUF) |
Switzerland |
$0.437B |
0.00 |
| Puma Biotechnology (PBYI) |
United States |
$0.394B |
0.00 |
| Prothena (PRTA) |
Ireland |
$0.393B |
0.00 |
| AC Immune SA (ACIU) |
Switzerland |
$0.378B |
24.35 |
| PDL BioPharma (PDLI) |
United States |
$0.376B |
8.97 |
| Biofrontera AG (BFRA) |
Germany |
$0.373B |
0.00 |
| Sinovac Biotech (SVA) |
China |
$0.371B |
0.00 |
| Arcus Biosciences (RCUS) |
United States |
$0.364B |
0.00 |
| Gritstone Oncology (GRTS) |
United States |
$0.361B |
0.00 |
| Starpharma Holdings (SPHRY) |
Australia |
$0.360B |
0.00 |
| Bellus Health (BLUSF) |
Canada |
$0.358B |
0.00 |
| Scholar Rock Holding (SRRK) |
United States |
$0.345B |
0.00 |
| Avid Bioservices (CDMO) |
United States |
$0.343B |
0.00 |
| Adaptimmune Therapeutics (ADAP) |
United Kingdom |
$0.342B |
0.00 |
| Merus (MRUS) |
Netherlands |
$0.341B |
0.00 |
| BioDelivery Sciences (BDSI) |
United States |
$0.341B |
0.00 |
| Albireo Pharma (ALBO) |
United States |
$0.340B |
0.00 |
| Acorda Therapeutics (ACOR) |
United States |
$0.332B |
5.85 |
| Agenus (AGEN) |
United States |
$0.330B |
0.00 |
| Achillion Pharmaceuticals (ACHN) |
United States |
$0.330B |
0.00 |
| Prometic Life Sciences (PFSCD) |
Canada |
$0.322B |
0.00 |
| Kadmon Holdings (KDMN) |
United States |
$0.321B |
0.00 |
| Theratechnologies (THERF) |
Canada |
$0.320B |
0.00 |
| Sorrento Therapeutics (SRNE) |
United States |
$0.319B |
0.00 |
| Syros Pharmaceuticals (SYRS) |
United States |
$0.314B |
0.00 |
| Protagonist Therapeutics (PTGX) |
United States |
$0.307B |
0.00 |
| Senesco Technologies (ELOX) |
United States |
$0.297B |
0.00 |
| AMAG Pharmaceuticals (AMAG) |
United States |
$0.295B |
0.00 |
| Cellular Biomedicine (CBMG) |
United States |
$0.277B |
0.00 |
| Inovio Pharmaceuticals (INO) |
United States |
$0.274B |
0.00 |
| Kindred Biosciences (KIN) |
United States |
$0.264B |
0.00 |
| Xenon Pharmaceuticals (XENE) |
Canada |
$0.258B |
0.00 |
| Sutro Biopharma (STRO) |
United States |
$0.256B |
0.00 |
| Syndax Pharmaceuticals (SNDX) |
United States |
$0.246B |
0.00 |
| PHASEBIO PHARMA (PHAS) |
United States |
$0.246B |
0.00 |
| ChromaDex (CDXC) |
United States |
$0.245B |
0.00 |
| Kamada (KMDA) |
Israel |
$0.239B |
9.28 |
| Dynavax Technologies (DVAX) |
United States |
$0.238B |
0.00 |
| Geron (GERN) |
United States |
$0.229B |
0.00 |
| Pieris Pharmaceuticals (PIRS) |
United States |
$0.225B |
0.00 |
| ADMA Biologics Inc (ADMA) |
United States |
$0.224B |
0.00 |
| Athersys (ATHX) |
United States |
$0.213B |
0.00 |
| Aeglea BioTherapeutics (AGLE) |
United States |
$0.202B |
0.00 |
| Five Prime Therapeutics (FPRX) |
United States |
$0.202B |
0.00 |
| MannKind (MNKD) |
United States |
$0.201B |
0.00 |
| Mersana Therapeutics (MRSN) |
United States |
$0.200B |
0.00 |
| Cerecor (CERC) |
United States |
$0.197B |
0.00 |
| Affimed (AFMD) |
Germany |
$0.193B |
0.00 |
| OSMOTICA PHARM (OSMT) |
United States |
$0.184B |
0.00 |
| POXEL SA FRANCE (PXXLF) |
|
$0.184B |
0.00 |
| Abeona Therapeutics (ABEO) |
United States |
$0.184B |
0.00 |
| Synlogic (SYBX) |
United States |
$0.179B |
0.00 |
| Enzo Biochem (ENZ) |
United States |
$0.174B |
0.00 |
| Spero Therapeutics (SPRO) |
United States |
$0.174B |
0.00 |
| Compugen (CGEN) |
Israel |
$0.172B |
0.00 |
| Arsanis (XFOR) |
United States |
$0.168B |
0.00 |
| Newron Pharmaceuticals SpA (NWPHF) |
|
$0.165B |
0.00 |
| XOMA (XOMA) |
United States |
$0.165B |
0.00 |
| Nicox SA (NICXF) |
France |
$0.161B |
0.00 |
| Cue Biopharma (CUE) |
United States |
$0.157B |
0.00 |
| EYEPOINT PHARMACEUTICALS, INC (EYPT) |
United States |
$0.156B |
0.00 |
| Strongbridge Biopharma (SBBP) |
United States |
$0.150B |
8.66 |
| Liquidia Technologies (LQDA) |
United States |
$0.144B |
0.00 |
| Celyad SA (CYAD) |
Belgium |
$0.142B |
0.00 |
| Alcobra (ARCT) |
United States |
$0.141B |
0.00 |
| OvaScience (MLND) |
United States |
$0.141B |
0.00 |
| Adocia (ADOCY) |
France |
$0.140B |
0.00 |
| Windtree Therapeutics (WINT) |
United States |
$0.138B |
0.00 |
| Dyadic (DYAI) |
United States |
$0.136B |
0.00 |
| TOCAGEN INC (TOCA) |
United States |
$0.135B |
0.00 |
| Northwest Biotherapeutics (NWBO) |
United States |
$0.130B |
0.00 |
| Seres Therapeutics (MCRB) |
United States |
$0.127B |
0.00 |
| Aptinyx (APTX) |
United States |
$0.125B |
0.00 |
| NantKwest (NK) |
United States |
$0.121B |
0.00 |
| AVEO Pharmaceuticals (AVEO) |
United States |
$0.114B |
0.00 |
| Aduro Biotech (ADRO) |
United States |
$0.114B |
0.00 |
| Nymox Pharmaceutical (NYMX) |
Canada |
$0.110B |
0.00 |
| Novavax (NVAX) |
United States |
$0.108B |
0.00 |
| Paratek Pharmaceuticals (PRTK) |
United States |
$0.108B |
0.00 |
| Verastem (VSTM) |
United States |
$0.106B |
0.00 |
| Checkpoint Therapeutics (CKPT) |
United States |
$0.104B |
0.00 |
| Menlo Therapeutics (MNLO) |
United States |
$0.103B |
0.00 |
| ASLAN Pharmaceuticals (ASLN) |
Singapore |
$0.103B |
0.00 |
| Catalyst Biosciences (CBIO) |
United States |
$0.099B |
0.00 |
| Arbutus Biopharma (ABUS) |
Canada |
$0.098B |
0.00 |
| SESEN BIO, INC (SESN) |
United States |
$0.098B |
0.00 |
| Trevena (TRVN) |
United States |
$0.094B |
0.00 |
| Fortress Biotech (FBIO) |
United States |
$0.089B |
0.00 |
| Pluristem Therapeutics (PSTI) |
Israel |
$0.088B |
0.00 |
| ANIXA BIOSCIENCES INC (ANIX) |
United States |
$0.087B |
0.00 |
| Spring Bank Pharmaceuticals (SBPH) |
United States |
$0.084B |
0.00 |
| Catabasis Pharmaceuticals (CATB) |
United States |
$0.082B |
0.00 |
| Aridis Pharmaceuticals (ARDS) |
United States |
$0.080B |
0.00 |
| Unum Therapeutics (UMRX) |
United States |
$0.079B |
0.00 |
| VBI Vaccines (VBIV) |
United States |
$0.079B |
0.00 |
| AquaBounty Technologies (AQB) |
United States |
$0.078B |
0.00 |
| Curis (CRIS) |
United States |
$0.076B |
0.00 |
| Selecta Biosciences (SELB) |
United States |
$0.076B |
0.00 |
| Merrimack Pharmaceuticals (MACK) |
United States |
$0.071B |
0.00 |
| Idera Pharmaceuticals (IDRA) |
United States |
$0.071B |
0.00 |
| Applied Genetic Technologies (AGTC) |
United States |
$0.071B |
38.80 |
| VTv Therapeutics (VTVT) |
United States |
$0.070B |
0.00 |
| Signal Genetics (MGEN) |
United States |
$0.070B |
0.00 |
| Orgenesis (ORGS) |
United States |
$0.067B |
0.00 |
| Oncobiologics (OTLK) |
United States |
$0.064B |
0.00 |
| Alimera Sciences (ALIM) |
United States |
$0.062B |
0.00 |
| Antibe Therapeutics (ATBPF) |
Canada |
$0.061B |
0.00 |
| ARAVIVE, INC (ARAV) |
United States |
$0.060B |
0.00 |
| NewLink Genetics (NLNK) |
United States |
$0.060B |
0.00 |
| Organovo Holdings (ONVO) |
United States |
$0.060B |
0.00 |
| Sunesis Pharmaceuticals (SNSS) |
United States |
$0.058B |
0.00 |
| Prima BioMed (IMMP) |
Australia |
$0.057B |
0.00 |
| AIT Therapeutics (XAIR) |
United States |
$0.057B |
0.00 |
| Ophthotech (ISEE) |
United States |
$0.048B |
0.00 |
| Vascular Biogenics (VBLT) |
Israel |
$0.048B |
0.00 |
| Vaccinex (VCNX) |
United States |
$0.047B |
0.00 |
| Proteostasis Therapeutics (PTI) |
United States |
$0.046B |
0.00 |
| DiaMedica Therapeutics (DMAC) |
United States |
$0.044B |
0.00 |
| Clearside Biomedical (CLSD) |
United States |
$0.043B |
0.00 |
| Entera Bio (ENTX) |
Israel |
$0.042B |
0.28 |
| Apricus Biosciences (SEEL) |
United States |
$0.041B |
0.00 |
| AEterna Zentaris (AEZS) |
United States |
$0.041B |
0.00 |
| INNOVATE BIOPHARMACEUTICALS, INC (INNT) |
United States |
$0.039B |
0.00 |
| Aptevo Therapeutics (APVO) |
United States |
$0.039B |
0.00 |
| Evogene (EVGN) |
Israel |
$0.039B |
0.00 |
| Celsion (CLSN) |
United States |
$0.037B |
0.00 |
| VIVUS (VVUS) |
United States |
$0.036B |
0.00 |
| Aerpio Pharmaceuticals (ARPO) |
United States |
$0.033B |
0.00 |
| Celldex Therapeutics (CLDX) |
United States |
$0.032B |
0.00 |
| Caladrius Biosciences (CLBS) |
United States |
$0.030B |
0.00 |
| Bionano Genomics (BNGO) |
United States |
$0.029B |
0.00 |
| Aytu Bioscience (AYTU) |
United States |
$0.028B |
0.00 |
| VistaGen Therapeutics (VTGN) |
United States |
$0.026B |
0.00 |
| Soligenix (SNGX) |
United States |
$0.019B |
0.00 |
| Novogen (KZIA) |
Australia |
$0.018B |
0.00 |
| Fibrocell Science Inc (FCSC) |
United States |
$0.018B |
0.00 |
| Cleveland BioLabs (CBLI) |
United States |
$0.017B |
0.00 |
| CollPlant Holdings (CLGN) |
Israel |
$0.017B |
0.00 |
| Titan Pharmaceuticals (TTNP) |
United States |
$0.017B |
0.00 |
| TRACON Pharmaceuticals (TCON) |
United States |
$0.017B |
0.00 |
| Vical (VICL) |
United States |
$0.016B |
0.00 |
| Pulmatrix (PULM) |
United States |
$0.016B |
0.00 |
| MYOS RENS Technology (MYOS) |
United States |
$0.016B |
0.00 |
| Novelion Therapeutics (NVLN) |
Canada |
$0.013B |
0.00 |
| TrovaGene (TROV) |
United States |
$0.011B |
0.00 |
| Genetic Technologies (GENE) |
Australia |
$0.011B |
0.00 |
| Flex Pharma (FLKS) |
United States |
$0.011B |
0.00 |
| IMMURON (IMRN) |
Australia |
$0.011B |
0.00 |
| Advaxis (ADXS) |
United States |
$0.010B |
0.00 |
| Prana Biotechnology (ATHE) |
Australia |
$0.010B |
0.00 |
| Cyclacel Pharmaceuticals (CYCC) |
United States |
$0.009B |
0.00 |
| Benitec Biopharma (BNTC) |
Australia |
$0.008B |
0.00 |
| Neuralstem (CUR) |
United States |
$0.006B |
0.00 |
| Cytori Therapeutics Inc (CYTX) |
United States |
$0.005B |
0.00 |
| Stellar Biotechnologies (EDSA) |
United States |
$0.004B |
0.00 |
